Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women

被引：127

作者：

Tanaka, Toshihiro ^{[1
]}

Nakajima, Ken ^{[2
]}

Murashima, Atsuko ^{[2
]}

Garcia-Bournissen, Facundo ^{[1
]}

Koren, Gideon ^{[1
]}

Ito, Shinya ^{[1
]}

机构：

[1] Univ Toronto, Hosp Sick Children, Dept Paediat, Div Clin Pharmacol & Toxicol,Motherisk Program, Toronto, ON M5G 1X8, Canada

[2] Natl Ctr Child Hlth & Dev, Japan Drug Informat Inst Pregnancy, Tokyo, Japan

来源：

CANADIAN MEDICAL ASSOCIATION JOURNAL | 2009年 / 181卷 / 1-2期

关键词：

OSELTAMIVIR; ZANAMIVIR; PHARMACOKINETICS; IMPACT; RISK;

D O I：

10.1503/cmaj.090866

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：55 / 58

页数：4

共 28 条

[1]

ACOG Committee on Obstetric Practice, 2004, Obstet Gynecol, V104, P1125

[2] Maternal influenza during pregnancy and risk of congenital abnormalities in offspring [J].

Acs, N ;

Bánhidy, F ;

Puhó, E ;

Czeizel, AE .

BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2005, 73 (12) :989-996

[3]

Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P453

[4]

[Anonymous], INFECT DIS OBSTET GY

[5]

[Anonymous], WHAT PREGN WOM SHOUL

[6]

[Anonymous], INT GUID ANT REC PAT

[7]

[Anonymous], PREGN WOM NOV INFL A

[8] Pharmacokinetics of zanamivir after intravenous, oral, inhaled or intranasal administration to healthy volunteers [J].

Cass, LMR ;

Efthymiopoulos, C ;

Bye, A .

CLINICAL PHARMACOKINETICS, 1999, 36 (Suppl 1) :1-11

[9]

*CDCP, 2009, NOV H1N1 FLU SWIN FL

[10]

CENTERS F, 2009, MMWR-MORBID MORTAL W, V58, P433

← 1 2 3 →